Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
The Activity of KIF14, Mieap, and EZR in a New Type of the Invasive Component, Torpedo-Like Structures, Predetermines the Metastatic Potential of Breast Cancer.

Cancers

Gerashchenko TS, Zolotaryova SY, Kiselev AM, Tashireva LA, Novikov NM, Krakhmal NV, Cherdyntseva NV, Zavyalova MV, Perelmuter VM, Denisov EV.
PMID: 32679794
Cancers (Basel). 2020 Jul 15;12(7). doi: 10.3390/cancers12071909.

Intratumor morphological heterogeneity reflects patterns of invasive growth and is an indicator of the metastatic potential of breast cancer. In this study, we used this heterogeneity to identify molecules associated with breast cancer invasion and metastasis. The gene expression...

Cite
Gerashchenko TS, Zolotaryova SY, Kiselev AM, et al. The Activity of KIF14, Mieap, and EZR in a New Type of the Invasive Component, Torpedo-Like Structures, Predetermines the Metastatic Potential of Breast Cancer. Cancers (Basel). 2020;12(7)doi: 10.3390/cancers12071909.
Gerashchenko, T. S., Zolotaryova, S. Y., Kiselev, A. M., Tashireva, L. A., Novikov, N. M., Krakhmal, N. V., Cherdyntseva, N. V., Zavyalova, M. V., Perelmuter, V. M., & Denisov, E. V. (2020). The Activity of KIF14, Mieap, and EZR in a New Type of the Invasive Component, Torpedo-Like Structures, Predetermines the Metastatic Potential of Breast Cancer. Cancers, 12(7), . https://doi.org/10.3390/cancers12071909
Gerashchenko, Tatiana S, et al. "The Activity of KIF14, Mieap, and EZR in a New Type of the Invasive Component, Torpedo-Like Structures, Predetermines the Metastatic Potential of Breast Cancer." Cancers vol. 12,7 (2020). doi: https://doi.org/10.3390/cancers12071909
Gerashchenko TS, Zolotaryova SY, Kiselev AM, Tashireva LA, Novikov NM, Krakhmal NV, Cherdyntseva NV, Zavyalova MV, Perelmuter VM, Denisov EV. The Activity of KIF14, Mieap, and EZR in a New Type of the Invasive Component, Torpedo-Like Structures, Predetermines the Metastatic Potential of Breast Cancer. Cancers (Basel). 2020 Jul 15;12(7). doi: 10.3390/cancers12071909. PMID: 32679794; PMCID: PMC7409151.
Copy Download .nbib Format: NLM
Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity.

Acta naturae

Gerashchenko TS, Zavyalova MV, Denisov EV, Krakhmal NV, Pautova DN, Litviakov NV, Vtorushin SV, Cherdyntseva NV, Perelmuter VM.
PMID: 28461975
Acta Naturae. 2017 Jan-Mar;9(1):56-67.

Breast cancer (BC) demonstrates considerable intratumoral morphological heterogeneity. The aim of this work was to evaluate the relationship among different morphological structures, the rate of metastasis, and efficacy of neoadjuvant chemotherapy (NAC) in NAC-treated (

Cite
Gerashchenko TS, Zavyalova MV, Denisov EV, et al. Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity. Acta Naturae. 2017;9(1):56-67
Gerashchenko, T. S., Zavyalova, M. V., Denisov, E. V., Krakhmal, N. V., Pautova, D. N., Litviakov, N. V., Vtorushin, S. V., Cherdyntseva, N. V., & Perelmuter, V. M. (2017). Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity. Acta naturae, 9(1), 56-67.
Gerashchenko, T S, et al. "Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity." Acta naturae vol. 9,1 (2017): 56-67.
Gerashchenko TS, Zavyalova MV, Denisov EV, Krakhmal NV, Pautova DN, Litviakov NV, Vtorushin SV, Cherdyntseva NV, Perelmuter VM. Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity. Acta Naturae. 2017 Jan-Mar;9(1):56-67. PMID: 28461975; PMCID: PMC5406661.
Copy Download .nbib Format: NLM
Cancer Invasion: Patterns and Mechanisms.

Acta naturae

Krakhmal NV, Zavyalova MV, Denisov EV, Vtorushin SV, Perelmuter VM.
PMID: 26085941
Acta Naturae. 2015 Apr-Jun;7(2):17-28.

Cancer invasion and the ability of malignant tumor cells for directed migration and metastasis have remained a focus of research for many years. Numerous studies have confirmed the existence of two main patterns of cancer cell invasion: collective cell...

Cite
Krakhmal NV, Zavyalova MV, Denisov EV, et al. Cancer Invasion: Patterns and Mechanisms. Acta Naturae. 2015;7(2):17-28
Krakhmal, N. V., Zavyalova, M. V., Denisov, E. V., Vtorushin, S. V., & Perelmuter, V. M. (2015). Cancer Invasion: Patterns and Mechanisms. Acta naturae, 7(2), 17-28.
Krakhmal, N V, et al. "Cancer Invasion: Patterns and Mechanisms." Acta naturae vol. 7,2 (2015): 17-28.
Krakhmal NV, Zavyalova MV, Denisov EV, Vtorushin SV, Perelmuter VM. Cancer Invasion: Patterns and Mechanisms. Acta Naturae. 2015 Apr-Jun;7(2):17-28. PMID: 26085941; PMCID: PMC4463409.
Copy Download .nbib Format: NLM
Functionalization of Biomedical Ti6Al4V via In Situ Alloying by Cu during Laser Powder Bed Fusion Manufacturing.

Materials (Basel, Switzerland)

Krakhmalev P, Yadroitsev I, Yadroitsava I, de Smidt O.
PMID: 28972546
Materials (Basel). 2017 Oct 03;10(10). doi: 10.3390/ma10101154.

The modern medical industry successfully utilizes Laser Powder Bed Fusion (LPBF) to manufacture complex custom implants. Ti6Al4V is one of the most commonly used biocompatible alloys. In surgery practice, infection at the bone-implant interface is one of the key...

Cite
Krakhmalev P, Yadroitsev I, Yadroitsava I, et al. Functionalization of Biomedical Ti6Al4V via In Situ Alloying by Cu during Laser Powder Bed Fusion Manufacturing. Materials (Basel). 2017;10(10)doi: 10.3390/ma10101154.
Krakhmalev, P., Yadroitsev, I., Yadroitsava, I., & de Smidt, O. (2017). Functionalization of Biomedical Ti6Al4V via In Situ Alloying by Cu during Laser Powder Bed Fusion Manufacturing. Materials (Basel, Switzerland), 10(10), . https://doi.org/10.3390/ma10101154
Krakhmalev, Pavel, et al. "Functionalization of Biomedical Ti6Al4V via In Situ Alloying by Cu during Laser Powder Bed Fusion Manufacturing." Materials (Basel, Switzerland) vol. 10,10 (2017). doi: https://doi.org/10.3390/ma10101154
Krakhmalev P, Yadroitsev I, Yadroitsava I, de Smidt O. Functionalization of Biomedical Ti6Al4V via In Situ Alloying by Cu during Laser Powder Bed Fusion Manufacturing. Materials (Basel). 2017 Oct 03;10(10). doi: 10.3390/ma10101154. PMID: 28972546; PMCID: PMC5666960.
Copy Download .nbib Format: NLM
In Vitro Characterization of In Situ Alloyed Ti6Al4V(ELI)-3 at.% Cu Obtained by Laser Powder Bed Fusion.

Materials (Basel, Switzerland)

Vilardell AM, Krakhmalev P, Yadroitsava I, Yadroitsev I, Garcia-Giralt N.
PMID: 34885415
Materials (Basel). 2021 Nov 27;14(23). doi: 10.3390/ma14237260.

The intensive cytotoxicity of pure copper is effectively kills bacteria, but it can compromise cellular behavior, so a rational balance must be found for Cu-loaded implants. In the present study, the individual and combined effect of surface composition and...

Cite
Vilardell AM, Krakhmalev P, Yadroitsava I, et al. In Vitro Characterization of In Situ Alloyed Ti6Al4V(ELI)-3 at.% Cu Obtained by Laser Powder Bed Fusion. Materials (Basel). 2021;14(23)doi: 10.3390/ma14237260.
Vilardell, A. M., Krakhmalev, P., Yadroitsava, I., Yadroitsev, I., & Garcia-Giralt, N. (2021). In Vitro Characterization of In Situ Alloyed Ti6Al4V(ELI)-3 at.% Cu Obtained by Laser Powder Bed Fusion. Materials (Basel, Switzerland), 14(23), . https://doi.org/10.3390/ma14237260
Vilardell, Anna Martín, et al. "In Vitro Characterization of In Situ Alloyed Ti6Al4V(ELI)-3 at.% Cu Obtained by Laser Powder Bed Fusion." Materials (Basel, Switzerland) vol. 14,23 (2021). doi: https://doi.org/10.3390/ma14237260
Vilardell AM, Krakhmalev P, Yadroitsava I, Yadroitsev I, Garcia-Giralt N. In Vitro Characterization of In Situ Alloyed Ti6Al4V(ELI)-3 at.% Cu Obtained by Laser Powder Bed Fusion. Materials (Basel). 2021 Nov 27;14(23). doi: 10.3390/ma14237260. PMID: 34885415; PMCID: PMC8658412.
Copy Download .nbib Format: NLM
In Vitro Characterization of In Situ Alloyed Ti6Al4V(ELI)-3 at.% Cu Obtained by Laser Powder Bed Fusion.

Materials (Basel, Switzerland)

Vilardell AM, Krakhmalev P, Yadroitsava I, Yadroitsev I, Garcia-Giralt N.
PMID: 34885415
Materials (Basel). 2021 Nov 27;14(23). doi: 10.3390/ma14237260.

The intensive cytotoxicity of pure copper is effectively kills bacteria, but it can compromise cellular behavior, so a rational balance must be found for Cu-loaded implants. In the present study, the individual and combined effect of surface composition and...

Cite
Vilardell AM, Krakhmalev P, Yadroitsava I, et al. In Vitro Characterization of In Situ Alloyed Ti6Al4V(ELI)-3 at.% Cu Obtained by Laser Powder Bed Fusion. Materials (Basel). 2021;14(23)doi: 10.3390/ma14237260.
Vilardell, A. M., Krakhmalev, P., Yadroitsava, I., Yadroitsev, I., & Garcia-Giralt, N. (2021). In Vitro Characterization of In Situ Alloyed Ti6Al4V(ELI)-3 at.% Cu Obtained by Laser Powder Bed Fusion. Materials (Basel, Switzerland), 14(23), . https://doi.org/10.3390/ma14237260
Vilardell, Anna Martín, et al. "In Vitro Characterization of In Situ Alloyed Ti6Al4V(ELI)-3 at.% Cu Obtained by Laser Powder Bed Fusion." Materials (Basel, Switzerland) vol. 14,23 (2021). doi: https://doi.org/10.3390/ma14237260
Vilardell AM, Krakhmalev P, Yadroitsava I, Yadroitsev I, Garcia-Giralt N. In Vitro Characterization of In Situ Alloyed Ti6Al4V(ELI)-3 at.% Cu Obtained by Laser Powder Bed Fusion. Materials (Basel). 2021 Nov 27;14(23). doi: 10.3390/ma14237260. PMID: 34885415.
Copy Download .nbib Format: NLM
Markers of Cancer Cell Invasion: Are They Good Enough?.

Journal of clinical medicine

Gerashchenko TS, Novikov NM, Krakhmal NV, Zolotaryova SY, Zavyalova MV, Cherdyntseva NV, Denisov EV, Perelmuter VM.
PMID: 31344926
J Clin Med. 2019 Jul 24;8(8). doi: 10.3390/jcm8081092.

Invasion, or directed migration of tumor cells into adjacent tissues, is one of the hallmarks of cancer and the first step towards metastasis. Penetrating to adjacent tissues, tumor cells form the so-called invasive front/edge. The cellular plasticity afforded by...

Cite
Gerashchenko TS, Novikov NM, Krakhmal NV, et al. Markers of Cancer Cell Invasion: Are They Good Enough?. J Clin Med. 2019;8(8)doi: 10.3390/jcm8081092.
Gerashchenko, T. S., Novikov, N. M., Krakhmal, N. V., Zolotaryova, S. Y., Zavyalova, M. V., Cherdyntseva, N. V., Denisov, E. V., & Perelmuter, V. M. (2019). Markers of Cancer Cell Invasion: Are They Good Enough?. Journal of clinical medicine, 8(8), . https://doi.org/10.3390/jcm8081092
Gerashchenko, Tatiana S, et al. "Markers of Cancer Cell Invasion: Are They Good Enough?." Journal of clinical medicine vol. 8,8 (2019). doi: https://doi.org/10.3390/jcm8081092
Gerashchenko TS, Novikov NM, Krakhmal NV, Zolotaryova SY, Zavyalova MV, Cherdyntseva NV, Denisov EV, Perelmuter VM. Markers of Cancer Cell Invasion: Are They Good Enough?. J Clin Med. 2019 Jul 24;8(8). doi: 10.3390/jcm8081092. PMID: 31344926; PMCID: PMC6723901.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries